For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Taoyuan, Taiwan
NCT Number: NCT00475358
Study F1J-MC-SBBT will examine the effect of duloxetine treatment in women with SUI. The inclusion and exclusion criteria of this Phase 3 study will ensure that all subjects have a clinical diagnosis of SUI.
Looking for future studies?
Notify Me20 year and older
Female
Interventional
Phase 3
Taoyuan, Taiwan
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Eli Lilly and Company
Industry
Efficacy and Safety of Duloxetine Compared With Placebo in Subjects With Stress Urinary Incontinence
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04114266
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Ghent, Belgium
View Trial DetailsNCT03325543
Behavior, Female Urogenital Diseases
São Paulo, Brazil
View Trial DetailsNCT04171531
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Birmingham, Alabama, United States
View Trial DetailsNCT03672461
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Palo Alto, California, United States
View Trial Details